Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28012880 | 0.87 | KDM4E (0.32) | LMNA | |
| SCHEMBL1119824 | 0.81 | LMNA (0.46) | GABRR1LMNA | |
| SCHEMBL7568558 | 0.79 | ALDH1A1 (0.39) | GABRR1LMNA | |
| SCHEMBL13192615 | 0.79 | CYP1A2 (0.30) | GABRR1LMNA | |
| SCHEMBL27959803 | 0.79 | — | — | |
| SCHEMBL18930093 | 0.74 | MGAM (0.38) | LMNA | |
| SCHEMBL3980744 | 0.74 | ALDH1A1 (0.33) | — | |
| SCHEMBL4078147 | 0.74 | — | — | |
| SCHEMBL27665160 | 0.73 | CA2 (0.42) | — | |
| SCHEMBL18930173 | 0.71 | CYP1A2 (0.41) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024041544-A9 | A METHOD OF PREPARING AN ANTIBODY WITH SITE-SPECIFIC MODIFICATIONS | SUZHOU BIOREINNO BIOTECHNOLOGY LIMITED COMPANY (CN) | 2025-01-30 | — | — | WO | disclosed |
| WO-2024041542-A1 | A METHOD FOR PROGRAMMATICALLY MANAGING ANTIBODY DISULFIDE BONDS SITE-SPECIFIC MODIFICATION | SUZHOU BIOREINNO BIOTECHNOLOGY LIMITED COMPANY (CN) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024041541-A1 | A NOVEL THIOL REDUCTANT, METHOD AND USE THEREOF | SUZHOU BIOREINNO BIOTECHNOLOGY LIMITED COMPANY (CN) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024044520-A1 | BIOCOMPATIBLE PARAHYDROGEN HYPERPOLARIZED SOLUTIONS BY PRECIPITATION AND RE-DISSOLUTION | NORTH CAROLINA STATE UNIVERSITY (US) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024041543-A1 | A METHOD OF PREPARING AN ANTIBODY WITH THIOL GROUP SITE-SPECIFIC MODIFICATIONS AND USE OF TCEP | SUZHOU BIOREINNO BIOTECHNOLOGY LIMITED COMPANY (CN) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024041544-A1 | A METHOD OF PREPARING AN ANTIBODY WITH SITE-SPECIFIC MODIFICATIONS | SUZHOU BIOREINNO BIOTECHNOLOGY LIMITED COMPANY (CN) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024041545-A1 | A NOVEL THIOL REDUCTANT, PREPARATION METHOD AND USE THEREOF | SUZHOU BIOREINNO BIOTECHNOLOGY LIMITED COMPANY (CN) | 2024-02-29 | — | — | WO | disclosed |
| EP-2173169-A1 | NASAL AND OPHTHALMIC DELIVERY OF AQUEOUS CORTICOSTEROID SOLUTIONS | CyDex Pharmaceuticals, Inc. (US) | 2010-04-14 | — | — | EP | disclosed |
| WO-2009003199-A1 | NASAL AND OPHTHALMIC DELIVERY OF AQUEOUS CORTICOSTEROID SOLUTIONS | CYDEX PHARMACEUTICALS, INC. (US) | 2008-12-31 | — | — | WO | disclosed |
| EP-1687337-A1 | A METHOD FOR THE TREATMENT OF MALIGNANT DISEASES BY INHIBITING NUCLEOLIN | University of Louisville Research Foundation (US) | 2006-08-09 | — | — | EP | disclosed |
| WO-2005035579-A1 | A METHOD FOR THE TREATMENT OF MALIGANT DISEASES BY INHIBITING NUCLEOLIN | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2005-04-21 | — | — | WO | disclosed |
| EP-1255576-A1 | MINERAL-POLYMER HYBRID COMPOSITION | Biosyntech Canada Inc. (CA) | 2002-11-13 | — | — | EP | disclosed |
| WO-2001041822-A1 | MINERAL-POLYMER HYBRID COMPOSITION | BIOSYNTECH CANADA INC. (CA) | 2001-06-14 | — | — | WO | disclosed |
| US-6048390-A | DYE HAVING AT LEAST ONE CARBOXYL GROUP IN THE FORM OF A FREE ACID; A SECONDARY OR TERTIARY AMINE; ALKALI METAL HYDROXIDE | FUJI XEROX CO., LTD. (JP) | 2000-04-11 | — | — | US | disclosed |